Anti-CD22 Chimeric Receptor T Cells in Pediatric and Young Adults With Recurrent or Refractory CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Dana-Farber Cancer Institute
Alliance for Clinical Trials in Oncology
Masonic Cancer Center, University of Minnesota
H. Lee Moffitt Cancer Center and Research Institute
University of Arizona
University of Wisconsin, Madison
St. Jude Children's Research Hospital
Baylor College of Medicine
Florida International University
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
Children's Oncology Group
Taproot Health
Seattle Children's Hospital
University Hospital, Basel, Switzerland
Novartis
Athenex, Inc.
Florida International University
Case Comprehensive Cancer Center
Atara Biotherapeutics
Children's Hospitals and Clinics of Minnesota
Scripps Health
Roswell Park Cancer Institute
Rutgers, The State University of New Jersey
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Novartis
Masonic Cancer Center, University of Minnesota
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Children's Oncology Group
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
University of Maryland, Baltimore